CD44 and sarcoma: The differences in CD44 expression among the stem-like cells (MSCs and CSCs/sarcomas) and differentiated tissues suggest a down-regulation event of CD44 upon differentiation into mature cells, acquiring a new basal level of CD44, corresponding to its novel biological functions, which is susceptible of up/down-regulation.